[go: up one dir, main page]

ES2154605A1 - Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 - Google Patents

Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3

Info

Publication number
ES2154605A1
ES2154605A1 ES009902042A ES9902042A ES2154605A1 ES 2154605 A1 ES2154605 A1 ES 2154605A1 ES 009902042 A ES009902042 A ES 009902042A ES 9902042 A ES9902042 A ES 9902042A ES 2154605 A1 ES2154605 A1 ES 2154605A1
Authority
ES
Spain
Prior art keywords
sup
alkyl
sub
hydrogen
arilpiperazina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009902042A
Other languages
English (en)
Other versions
ES2154605B1 (es
Inventor
Rodriguez Maria Luz Lopez
Cazorla Ignacio D Tejada
Ortega Maria Jose Morcillo
Bellinda Benhamusalama
Atance Jose Antonio Ramos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Priority to ES9902042A priority Critical patent/ES2154605B1/es
Publication of ES2154605A1 publication Critical patent/ES2154605A1/es
Application granted granted Critical
Publication of ES2154605B1 publication Critical patent/ES2154605B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninérgicos 5-HT{sub, 1A} y 5- HT{sub, 3}. La presente invención trata de nuevos compuestos de fórmula general I donde X es un grupo amido, tioamido, éster, cetona, hidroximetilo; R{sup, 1} es hidrógeno, halógeno, alquilo, alcoxi; R{sup, 2} es hidrógeno, nitro, amino; R{sup, 3} es hidrógeno, alquilo; R{sup, 4} es alquilo, arilo, heteroarilo; n es igual a 1-4; y la subunidad azabicíclica es azabiciclo [x.y.z] alquilo. Se describen los métodos de preparación de dichos compuestos, los cuales presentan afinidad por los receptores serotoninérgicos 5-HT{sub, 1A} y 5-HT{sub, 3} lo que indica su interés desde el punto de vista terapéutico para el tratamiento de trastornos del sistema nervioso central (SNC).
ES9902042A 1999-09-14 1999-09-14 Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 Expired - Fee Related ES2154605B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9902042A ES2154605B1 (es) 1999-09-14 1999-09-14 Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9902042A ES2154605B1 (es) 1999-09-14 1999-09-14 Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3

Publications (2)

Publication Number Publication Date
ES2154605A1 true ES2154605A1 (es) 2001-04-01
ES2154605B1 ES2154605B1 (es) 2001-11-16

Family

ID=8309929

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9902042A Expired - Fee Related ES2154605B1 (es) 1999-09-14 1999-09-14 Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3

Country Status (1)

Country Link
ES (1) ES2154605B1 (es)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088093A1 (en) * 2001-03-09 2002-11-07 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
WO2003076431A1 (en) * 2002-03-08 2003-09-18 Abbott Laboratories Benzimidazole-derivatives for the treatment of sexual dysfunction
US7256294B2 (en) 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
WO2007144005A1 (en) 2006-06-16 2007-12-21 H. Lundbeck A/S 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
US7351704B2 (en) 2004-02-18 2008-04-01 Theravance, Inc. Indazole-carboxamide compounds as 5-HT4 receptor agonists
US7351732B2 (en) 2002-07-31 2008-04-01 Schwarz Pharma S.L. Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications
US7351828B2 (en) 2001-03-09 2008-04-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
US7375114B2 (en) 2004-04-07 2008-05-20 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7396933B2 (en) 2004-11-05 2008-07-08 Theravance, Inc. Quinolinone-carboxamide compounds
US7399862B2 (en) 2004-11-05 2008-07-15 Theravance, Inc. 5-HT4 receptor agonist compounds
US7419989B2 (en) 2004-12-22 2008-09-02 Theravance, Inc. Indazole-carboxamide compounds
US7446114B2 (en) 2005-03-02 2008-11-04 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7759363B2 (en) 2005-05-25 2010-07-20 Theravance, Inc. Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
WO2020095912A1 (ja) * 2018-11-06 2020-05-14 第一三共株式会社 ベンズイミダゾール誘導体

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628549A1 (en) * 1993-05-21 1994-12-14 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) New 1-phenylmethyl benzimidazole piperazine derivatives
WO1996006846A1 (es) * 1994-09-01 1996-03-07 Universidad Complutense De Madrid Nuevos derivados de arilpiperazinas
ES2094690A1 (es) * 1994-11-22 1997-01-16 Univ Madrid Complutense Nuevos derivados de imida-piperazinas.
WO1997035860A1 (es) * 1996-03-22 1997-10-02 Universidad Complutense De Madrid Rectorado Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht3/5-ht¿4?
WO1998024771A1 (en) * 1996-12-02 1998-06-11 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives having a vasopressin antagonistic activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628549A1 (en) * 1993-05-21 1994-12-14 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) New 1-phenylmethyl benzimidazole piperazine derivatives
WO1996006846A1 (es) * 1994-09-01 1996-03-07 Universidad Complutense De Madrid Nuevos derivados de arilpiperazinas
ES2094690A1 (es) * 1994-11-22 1997-01-16 Univ Madrid Complutense Nuevos derivados de imida-piperazinas.
WO1997035860A1 (es) * 1996-03-22 1997-10-02 Universidad Complutense De Madrid Rectorado Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht3/5-ht¿4?
WO1998024771A1 (en) * 1996-12-02 1998-06-11 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives having a vasopressin antagonistic activity

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351828B2 (en) 2001-03-09 2008-04-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
US6960589B2 (en) 2001-03-09 2005-11-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
WO2002088093A1 (en) * 2001-03-09 2002-11-07 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
WO2003076431A1 (en) * 2002-03-08 2003-09-18 Abbott Laboratories Benzimidazole-derivatives for the treatment of sexual dysfunction
US7351732B2 (en) 2002-07-31 2008-04-01 Schwarz Pharma S.L. Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications
US8044045B2 (en) 2004-02-18 2011-10-25 Theravance, Inc. Indazole-carboxamide compounds as 5-HT4 receptor agonists
US7351704B2 (en) 2004-02-18 2008-04-01 Theravance, Inc. Indazole-carboxamide compounds as 5-HT4 receptor agonists
US7375114B2 (en) 2004-04-07 2008-05-20 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US9630960B2 (en) 2004-04-07 2017-04-25 Theravance Biopharma R&D Ip, Llc Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US9353106B2 (en) 2004-04-07 2016-05-31 Theravance Biopharma R&D Ip, Llc Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8962653B2 (en) 2004-04-07 2015-02-24 Theravance Biopharma R&D Ip, Llc Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US9873692B2 (en) 2004-04-07 2018-01-23 Theravance Biopharma R&D Ip, Llc Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7763637B2 (en) 2004-04-07 2010-07-27 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4, receptor agonists
US7396933B2 (en) 2004-11-05 2008-07-08 Theravance, Inc. Quinolinone-carboxamide compounds
US7399862B2 (en) 2004-11-05 2008-07-15 Theravance, Inc. 5-HT4 receptor agonist compounds
US7498442B2 (en) 2004-11-05 2009-03-03 Theravance, Inc. Quinolinone-carboxamide compounds
US7534889B2 (en) 2004-11-05 2009-05-19 Theravance, Inc. 5-HT4 receptor agonist compounds
US8003664B2 (en) 2004-12-22 2011-08-23 Theravance, Inc. Indazole-carboxamide compounds
US7419989B2 (en) 2004-12-22 2008-09-02 Theravance, Inc. Indazole-carboxamide compounds
US7786136B2 (en) 2004-12-22 2010-08-31 Theravance, Inc. Indazole-carboxamide compounds
US7875629B2 (en) 2005-03-02 2011-01-25 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
US7446114B2 (en) 2005-03-02 2008-11-04 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
US7622587B2 (en) 2005-05-25 2009-11-24 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
US8143279B2 (en) 2005-05-25 2012-03-27 Theravance, Inc. Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US10696656B2 (en) 2005-05-25 2020-06-30 Theravance Biopharma R&D Ip, Llc Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US8288550B2 (en) 2005-05-25 2012-10-16 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
US7759363B2 (en) 2005-05-25 2010-07-20 Theravance, Inc. Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
US8377964B2 (en) 2005-05-25 2013-02-19 Theravance, Inc. Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US10233172B2 (en) 2005-05-25 2019-03-19 Theravance Biopharma R&D Ip, Llc Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US11254655B2 (en) 2005-05-25 2022-02-22 Theravance Biopharma R&D Ip, Llc Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US9975877B2 (en) 2005-05-25 2018-05-22 Theravance Biopharma R&D Ip, Llc Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US7256294B2 (en) 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
US7897775B2 (en) 2005-05-25 2011-03-01 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
US9428489B2 (en) 2005-05-25 2016-08-30 Theravance Biopharma R&D Ip, Llc Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
US9101626B2 (en) 2006-06-16 2015-08-11 H. Lundbeck A/S Process for preparing 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or pharmaceutically acceptable salt thereof
US9095588B2 (en) 2006-06-16 2015-08-04 H. Lundbeck A/S Process for preparing 1-[2-(2,4-dimethylphenysulfanyl)-pheny]piperazine or pharmaceutically acceptable salt thereof
US9227946B2 (en) 2006-06-16 2016-01-05 H. Lundbeck A/S 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
US9125910B2 (en) 2006-06-16 2015-09-08 H. Lundbeck A/S 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
US9125908B2 (en) 2006-06-16 2015-09-08 H. Lundbeck A/S 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
WO2007144005A1 (en) 2006-06-16 2007-12-21 H. Lundbeck A/S 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
US9861630B1 (en) 2006-06-16 2018-01-09 H. Lundbeck A/S 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
US9125909B2 (en) 2006-06-16 2015-09-08 H. Lundbeck A/S 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
US8969355B2 (en) 2006-06-16 2015-03-03 H. Lundbeck A/S 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
US8722684B2 (en) 2006-06-16 2014-05-13 H. Lundbeck A/S 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
US11458134B2 (en) 2006-06-16 2022-10-04 H. Lundbeck A/S 1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
CN102617513A (zh) * 2006-06-16 2012-08-01 H.隆德贝克有限公司 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪
EA015287B1 (ru) * 2006-06-16 2011-06-30 Х. Лундбекк А/С 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазин в качестве соединения с сочетанием активности в отношении повторного захвата серотонина, 5-нти 5-нтдля лечения когнитивного нарушения
WO2020095912A1 (ja) * 2018-11-06 2020-05-14 第一三共株式会社 ベンズイミダゾール誘導体

Also Published As

Publication number Publication date
ES2154605B1 (es) 2001-11-16

Similar Documents

Publication Publication Date Title
ES2154605A1 (es) Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3
PE20001551A1 (es) Derivados de eter biarilico como inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
KR927003585A (ko) 헤테로사이클릭 화합물
DE3882614D1 (de) Indol-derivate.
PE20010009A1 (es) Derivados de fenil - y piridinilo como antagonistas del receptor de la neuroquinina 1
BRPI0415657A (pt) derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c
BR0210929A (pt) Derivados de indol com afinidade para o receptor 5-ht6
BR0211262A (pt) Tienopirimidinodionas e seu uso na modulação de doenças autoimunes
ES2157224T3 (es) Derivados de 5-arilindol y su uso como agonistas de serotonina (5-ht 1).
BR9915293A (pt) Compostos, método para preparar os mesmos, composições farmacêuticas, e métodos para preparar as mesmas, para tratar distúrbios de cns, e, para tratar ansiedade e/ou depressão.
AR015036A1 (es) Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento
PE20001029A1 (es) Derivados de dihidrobenzodioxina carboxamida y acetona
ES2154470T3 (es) Derivados de tetrahidroisoquinolina y su uso farmaceutico.
BRPI0411285A (pt) composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios
BRPI0517955A (pt) indolizinas substituìdas e derivados como agentes de snc
PT83726B (pt) Processo para preparacao de derivados da beta-carbolina substituidas por grupos fenoxi e de composicoes farmaceuticas que os contem
FI905957A (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
BR9907497A (pt) Compostos de imidazolina, um processo para seu preparo e compostos farmacêuticos contendo os mesmos
PT1018512E (pt) Novos derivados basicos de benzo¬e|isoindol-1-onas e pirrolo¬3,4-c|quinolin-1-onas com actividade antagonista de 5ht3 a sua preparacao e o seu uso terapeutico
PE20030187A1 (es) Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
SE9002727L (sv) Nya aminopropanolderivat, foerfarande foer deras framstaellning samt farmaceutiska kompositioner innehaallande desamma
ATE52776T1 (de) 1-phenyl-3-benzazepine.
HUP0003856A2 (hu) 6-Pirrolidin-2-ilpirindin-származékok, eljárás előállításukra és gyógyászati alkalmazásuk

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010401

Kind code of ref document: A1

Effective date: 20010401

FD2A Announcement of lapse in spain

Effective date: 20191230